Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacokinetics of Sirolimus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT05643872
What this trial is testing

A Study Evaluating the Safety and Pharmacokinetics of QTORIN Rapamycin 3.9% Anhydrous Gel in the Treatment of Adults With Pachyonychia Congenita

Who this might be right for
Pachyonychia Congenita
Palvella Therapeutics, Inc. 45
Early research (Phase 1)Study completedNCT01079286
What this trial is testing

Study of Nelfinavir and Temsirolimus in Patients With Advanced Cancers

Who this might be right for
Renal Cell CancerCancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 18
Early research (Phase 1)Study completedNCT01026402
What this trial is testing

Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of AZD2014

Who this might be right for
Advanced Solid Malignancies
AstraZeneca 172
Testing effectiveness (Phase 2)Study completedNCT03522298
What this trial is testing

Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma

Who this might be right for
Glioblastoma, Adult
Kazia Therapeutics Limited 30
Early research (Phase 1)Study completedNCT01353625
What this trial is testing

Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.

Who this might be right for
Glioblastoma MultiformeSquamous Cell Carcinoma of Head and NeckProstate Cancer+3 more
Celgene 118
Post-approval studies (Phase 4)UnknownNCT00166842
What this trial is testing

Sirolimus Blood Concentrations on Conversion From Oral Solution to Tablets

Who this might be right for
TransplantationKidney TransplantationImmunosuppression
National Taiwan University Hospital 40
Early research (Phase 1)Study completedNCT03730142
What this trial is testing

WXFL10030390 in Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Advanced Cancer
Shanghai Jiatan Pharmatech Co., Ltd 82
Early research (Phase 1)UnknownNCT05125523
What this trial is testing

Sirolimus for Injection (Albumin Bound) in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 264
Early research (Phase 1)Study completedNCT00927823
What this trial is testing

A Trial To Assess Safety And Tolerability Of PF-04691502 In Cancer Patients

Who this might be right for
Cancer
Pfizer 37
Early research (Phase 1)Looking for participantsNCT05661461
What this trial is testing

Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment

Who this might be right for
Tumor, SolidTumorAdvanced Solid Tumor
Aadi Bioscience, Inc. 28
Testing effectiveness (Phase 2)UnknownNCT00390195
What this trial is testing

Randomized Phase I/II of RAD001 in Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
National Health Research Institutes, Taiwan 134